NEW YORK (GenomeWeb) – Enterome and Nestle Health Science announced today that they have formed a new company to develop microbiome diagnostics for multiple indications including inflammatory bowel disease (IBD) and liver disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.